Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1191-1193, 2003; 10.1373/49.7.1191
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziebig, R.
Right arrow Articles by Sinha, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziebig, R.
Right arrow Articles by Sinha, P.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2003;49:1191-1193.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Renal Elimination of Troponin T and Troponin I

Reinhard Ziebig1,a, Andreas Lun1, Berthold Hocher2, Friedrich Priem1, Claudia Altermann1, Gernot Asmus3, Hartmut Kern4, Rolfdieter Krause2,5, Babette Lorenz2, Rainer Möbes6 and Pranav Sinha1

1 Institut für Laboratoriumsmedizin und Pathobiochemie,
2 Medizinische Klinik mit Schwerpunkt Nephrologie,
4 Klinik für Anaesthesiologie und operative Intensivmedizin, and
6 Medizinische Klinik mit Schwerpunkt Kardiologie, Pulmologie und Angiologie, Universitätsklinikum Charité, Campus Charité Mitte, Medizinische Fakultät der Humboldt Universität zu Berlin, Schumannstrasse 20-21, 10117 Berlin, Germany

3 Kuratorium für Dialyse und Nierentransplantation e. V., Dialysezentrum, Sonnenallee 47, 12045 Berlin, Germany

5 Kuratorium für Dialyse und Nierentransplantation e. V., Dialysezentrum–Moabit, Turmstasse 20 A, 10559 Berlin, Germany

aauthor for correspondence: fax 49-030-450-569-912, e-mail reinhard.ziebig@charite.de

The first 300 words of the full text of this article appear below.

Cardiovascular complications represent the predominant cause of death in patients in the terminal stage of renal failure. Increased concentrations of cardiac troponin T (cTnT) may be a valuable predictor of cardiac risk (1)(2). However, cardiac troponin I (cTnI), clinical symptoms, and electrocardiogram (ECG) indications may be absent in patients with a positive cTnT. This may be attributable to instability of the cTnI molecule (3) or dissimilar glomerular filtration of cTnT and cTnI (4). Positive cTnT values are of cardiac origin because the second generation of cTnT assays will not detect cTnT isoforms expressed in the skeletal muscle of hemodialysis patients (5). We therefore measured the cardiac troponins cTnT and cTnI in the plasma and urine of selected patients differing in their kidney function.

We examined 24 patients with increased plasma cTnT. Patients were grouped according to their basic disease and renal function as follows:

Group A included five patients (patients 1–5) who had suffered an acute myocardial infarction and three patients (patients 6–8) with cardiac damage as a result of heart surgery, all with normal or only slightly restricted glomerular filtration rate of >80 mL/min. All eight patients were male, with a mean (SD) age of 63 (11) years. Patients had clinically typical chest pain (with the exception of patient 8), and electrocardiography (ECG) showed signs of old myocardial infarction, signs of ST-segment reduction or elevation >0.1 mV with and without chest pain, or signs any arrhythmia of unknown origin.

Group B included two patients (patients 9 and 10) who had suffered an acute myocardial infarction and six patients (patients 11–16) with cardiac damage as a result of heart surgery; all had a substantially restricted glomerular filtration rate (only patient 9 had values for creatinine and creatinine clearance that were . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
R. Wiessner, K. Hannemann-Pohl, R. Ziebig, H. Grubitzsch, B. Hocher, O. Vargas-Hein, A. Lun, I. Schimke, and L. Liefeldt
Impact of kidney function on plasma troponin concentrations after coronary artery bypass grafting
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 231 - 238.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Yee-Moon Wang, C. Wai-Kei Lam, M. Wang, I. Hiu-Shuen Chan, W. B. Goggins, C.-M. Yu, S.-F. Lui, and J. E Sanderson
Prognostic Value of Cardiac Troponin T Is Independent of Inflammation, Residual Renal Function, and Cardiac Hypertrophy and Dysfunction in Peritoneal Dialysis Patients
Clin. Chem., May 1, 2007; 53(5): 882 - 889.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. N. Fahie-Wilson, D. J. Carmichael, M. P. Delaney, P. E. Stevens, E. M. Hall, and E. J. Lamb
Cardiac Troponin T Circulates in the Free, Intact Form in Patients with Kidney Failure
Clin. Chem., March 1, 2006; 52(3): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. Babuin and A. S. Jaffe
Troponin: the biomarker of choice for the detection of cardiac injury
Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. H.C. Diris, C. M. Hackeng, J. P. Kooman, Y. M. Pinto, W. T. Hermens, and M. P. van Dieijen-Visser
Impaired Renal Clearance Explains Elevated Troponin T Fragments in Hemodialysis Patients
Circulation, January 6, 2004; 109(1): 23 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.